Radziszewska Aneta U, Karczmarek-Borowska Bożenna, Wójcik Sebastian, Kluz Tomasz
Department of Epidemiology and Podkarpackie Cancer Registry, Podkarpackie Oncology Centre, Rzeszow, Poland.
Department of Oncology, Faculty of Medical Sciences, University of Rzeszow, Rzeszow, Poland.
Contemp Oncol (Pozn). 2018;22(3):151-157. doi: 10.5114/wo.2018.78935. Epub 2018 Sep 30.
The objective of the study was to analyse the survival rate of women with malignant ovarian tumours in the years 1990-2015 in the Podkarpacie province.
The database used for calculations covered 2399 cancer incidences verified at the end of 2014. The estimated relative survival rates were calculated by means of the Hakulinen method.
The number of recorded cases amounted to 196 in 2015 and was higher by 86.7% than in 1990. The rates of one-year, three-year, and five-year survival was 72.5%, 51.2%, and 42.4%, respectively.
Survival rates of women with ovarian cancer in the Podkarpacie province are comparable to survivals calculated for the entire Poland region. Despite the low risk factor, women suffering from ovarian adenocarcinoma have lower survival rates than others, and as many as 42.5% of patients with adenocarcinoma were diagnosed in stage IV. Steps aimed at improvement of detectability of ovarian cancers in the earliest possible stage should be taken. This should increase survival rates in each age group.
本研究的目的是分析1990 - 2015年波德卡尔帕希省恶性卵巢肿瘤女性的生存率。
用于计算的数据库涵盖了截至2014年底核实的2399例癌症发病病例。估计的相对生存率通过哈库利宁方法计算。
2015年记录的病例数为196例,比1990年高出86.7%。一年、三年和五年生存率分别为72.5%、51.2%和42.4%。
波德卡尔帕希省卵巢癌女性的生存率与整个波兰地区计算的生存率相当。尽管危险因素较低,但卵巢腺癌女性的生存率低于其他女性,多达42.5%的腺癌患者在IV期被诊断出来。应采取措施提高卵巢癌在尽可能早期的可检测性。这将提高各年龄组的生存率。